On the other hand, hyperleptinemia is associated with the progression of atherosclerosis through the secretion of pro-inflammatory cytokines, including IL-17 and other cytokines, to promote chronic inflammation and obesity-associated metabolic syndrome [28]. Here, IL17A is linked to atherosclerosis.